Clinical Trial Update: Rapalogues for Autism Phenotype in TSC: A Feasibility Study [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating rapalogue treatment for autism phenotype in tuberous sclerosis complex with self-injury; study completed and results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• rapalogue

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Tuberous Sclerosis Complex, Self-injury | Phase 2 | Status: COMPLETED | Results posted: 2021-03-29